Live Terminal | Security Analysis of BIO.DE
Options
Query: BIO.DE
TERMINAL beta
Version: 0.1
Timestamp: 1701400674.992866
Options
B7J.DE
48.43%
NUVL
40.38%
ALC.MC
33.58%
BWQ.DE
33.44%
AMI.F
25.58%
SPT.L
-33.31%
TISN.BR
-34.09%
ALO.PA
-41.60%
47IE.L
-44.23%
SSU
-52.02%
AAPL $189.97 -0.70%
AMD $122.31 -0.16%
AMZN $146.74 0.02%
BRK-B $362.68 0.24%
GOOG $138.22 -1.29%
IBM $155.18 0.03%
INTC $43.96 0.66%
JNJ $152.50 1.11%
JPM $153.54 0.14%
META $338.23 -0.95%
MSFT $377.43 -0.11%
O $53.91 1.13%
TSLA $235.45 0.53%
WMT $156.06 0.90%
QQQ $349.20 1.1265%
TLT $83.99 -0.4504%
VUAA.DE $73.38 0.0218%
VUSA.DE $74.16 0.0054%
FJPR.L $4.72 -0.2010%
VWRL.L $85.53 0.2579%
VWRP.L $84.57 0.1955%
EMGU.L $3.32 0.3553%
RDVY $43.87 0.9899%
FLOT $50.86 0.0197%
SCHZ $43.42 -0.2527%
C020.DE $21.34 0.0000%
IBB $113.03 0.5515%
LYP6.DE $195.28 0.4733%
MEUD.PA $195.07 0.4170%
IDWR.L $58.49 0.0513%
IQQW.DE $55.15 0.0689%
DFAX $21.68 1.1194%
EXS1.DE $123.30 0.1950%
XESC.L $5776.00 0.3911%
ACWV $93.85 0.9140%
VGWD.DE $52.70 -0.1327%
VHYD.L $55.91 0.0089%
FXKZ.ME $303.00 0.0000%
XIEE.DE $61.72 0.4394%

Latest articles

No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.

Sentiment statistics ?
BIO.DE
μ null
null
null

Financial Histories

Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.

Overview
BIO.DE
Day performance
BIO.DE $42.60
0.00 $ 0.00 %
BIO.DE
Price 42.60
Change Pct 0.00
Change Abs 0.00
Market Cap 1.5 billion
Eps 2.29
Pe Ratio 18.60
Outstanding Shares 34.3 million
Volume 50
Avg Volume 836
Industry Biotechnology
Sector Name Health Care
Country Short Name DE
Announcement Earnings 2023-11-02 10:59:00+00:00
All metrics in USD or %.
Risk Profiles

Please sign up and become a member to view all risk profiles.

Peers
BIO.DE
Same Country:
Same Decade:
Intraday: -0.97%
Focus

Use our 'Focus' approach as text-and chart based summaries of the financial standing for a company. They are solely focussing on the company's market, risks and chances.

Company descriptions
BIO.DE

Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis;